A study co-led by OHSU researchers finds private equity firms now own up to a quarter of behavioral health practices in some states. Jane Zhu, M.D., says: "It all comes down to what kind of care they’re providing. If these firms are expanding to increase access for people who otherwise wouldn’t be able to receive behavioral health treatment, that could be positive."

A study co-led by OHSU researchers finds private equity firms now own up to a quarter of behavioral health practices in some states. Jane Zhu, M.D., says: "It all comes down to what kind of care they’re providing. If these firms are expanding to increase access for people who otherwise wouldn’t be able to receive behavioral health treatment, that could be positive."

Roger Chou, M.D., from the Oregon Health & Science University in Portland, and colleagues performed a scoping review on definitions of long COVID and provide an overview of care models. Thirty-eight of 1,960 screened citations were included in a review.

Joel Nigg, Ph.D., discusses the effectiveness of white and pink noise in providing small benefits for people with attention-deficit/hyperactivity disorder: "The noise provides stimulation to the brain without providing information, and so it doesn’t distract.”

In a CNet article on the use of technology in reproductive health, Shaalini Ramanadhan, M.D., discusses the challenges people face in accurately tracking their fertility because the process requires consistent monitoring of different body signals: "I appreciate that people want to understand their bodies more. That they're curious about their body and want to see what their body is capable of."

Amad Masri, M.D., describes a clinical trial that found the investigational drug aficamten can help patients with a common heart condition take in and use significantly more oxygen while exercising: “By having more oxygen available during exercise, patients with obstructive hypertrophic cardiomyopathy can more easily walk, perform household chores and do other everyday tasks."

Alison Edelman, M.D., discusses her research presented at the 2024 ACOG Annual Clinical and Scientific Meeting regarding the impact of COVID-19 vaccination on menstrual cycles: "The number one thing is to be listening to your patients and If they do report a change, that very well could happen because of the COVID-19 vaccine."

Alison Edelman, M.D., discusses her research presented at the 2024 ACOG Annual Clinical and Scientific Meeting regarding the impact of COVID-19 vaccination on menstrual cycles: "The number one thing is to be listening to your patients and If they do report a change, that very well could happen because of the COVID-19 vaccine."

Phil and Penny Knight's philanthropic gifts to OHSU are mentioned in a Yahoo! Finance article on wealthy people who have made substantial donations to universities.

Tom Beer, M.D., addresses the importance of patient-reported outcomes, or PROs, as part of the FDA's review of new cancer drugs: "PROs have an important role and should be considered in most drug trials but may not be appropriate in every setting. While PROs are an invaluable tool to better understand the patient experience, like any important outcome measure, they should be used when clinically and scientifically indicated. That is often, but not always."